Month: August 2025

Ischemia Modified Albumin in Diabetic Foot Ulcers: Promising Marker or Incomplete Picture?

Ischemia-Modified Albumin in Diabetic Foot Ulcers: Promising Marker or Incomplete Picture?

Summary: A letter by **Seshadri Reddy Varikasuvu, PhD** (AIIMS, Deoghar) published in *International Journal of Lower Extremity Wounds* (ahead of print, August 2025) critically examines a study by Juttada et al. that explored serial monitoring of ischemia-modified albumin (IMA) as a biomarker for healing in diabetic foot ulcers (DFUs).

Key Reflections:

  • Varikasuvu acknowledges the novelty of using serial IMA measurements to reflect wound healing dynamics.
  • However, he raises concerns about the study’s predictive validity, noting limitations such as inadequate adjustment for baseline albumin levels and neglect of oxidative therapies like hyperbaric oxygen therapy.
  • The letter recommends that future biomarker research in DFUs should adopt a multi-marker strategy and account for oxidative stress variability to strengthen clinical utility.

Read the full letter in *International Journal of Lower Extremity Wounds*

Keywords:
ischemia-modified albumin (IMA),
diabetic foot ulcer,
biomarkers,
oxidative stress,
hyperbaric oxygen therapy,
wound healing monitoring

What is the knowledge, perceptions, and experiences of nurses regarding antimicrobial stewardship?

Nurses’ Views on Antimicrobial Stewardship: Gaps and Opportunities

Summary: A systematic review by Blackburn et al., published in Wound Practice and Research (June 2025), evaluated studies exploring nurses’ knowledge, perceptions, and experiences related to antimicrobial stewardship (AMS). The review identified significant gaps that limit nursing engagement—and highlighted clear pathways to strengthen their roles in AMS programs.

Key Findings:

  • Across seven studies, nurses consistently demonstrated limited knowledge of AMS principles, policies, and procedures—diminishing their confidence and involvement in stewardship efforts. :contentReference[oaicite:0]{index=0}
  • Common barriers include lack of structured training, unclear role boundaries, competing priorities, and organizational hierarchies that limit nursing autonomy. :contentReference[oaicite:1]{index=1}
  • Despite these challenges, nurses remain ideally positioned to support AMS through direct patient care—monitoring antimicrobial use, educating patients, and identifying early signs of infection. :contentReference[oaicite:2]{index=2}
  • The authors advocate for AMS programs that include nurse-targeted education, clarify nursing responsibilities, and cultivate interprofessional collaboration to strengthen AMS outcomes. :contentReference[oaicite:3]{index=3}

Read the full review in Wound Practice and Research

Keywords:
antimicrobial stewardship,
nurses involvement,
knowledge gaps,
interprofessional collaboration,
education and training,
policy and procedures

Advanced Wound Management from Nancy Morgan

Certification Options for WoundCareProf: Advanced Wound Management

Summary: WoundCareProf offers an **Advanced Wound Management Certification Course**, designed for licensed clinicians seeking board-recognized credentials. The program includes:

  • Self-paced, online training with up to **6 months access**, led by clinician experts in 37 structured learning modules.
  • Comprehensive curriculum aligned to national board standards, preparing attendees for certification through CMET, NAWCO, ABWM, or WOCNCB.
  • **Initial Certification Bundle:** $1,295 for the course alone, or $1,545 bundled with the CMET exam.
  • **Recertification Bundle:** $495 for course-only recertification (with active credentials) or $745 including exam credentials.
  • Features include micro-lesson format, knowledge checks, a final test, extended access if needed, and bonus 1-year membership in the Wound Care Professionals community.
  • Offers group/team rates and a “clinical bridge” pathway for clinicians building experience toward eligibility.

Learn more on WoundCareProf

Keywords:
Advanced Wound Management Certification,
board-recognized wound care credentials,
CMET,
NAWCO,
ABWM,
WOCNCB,
recertification,
clinical bridge program

WOCN® Member Alert: CMS Proposal May Limit Access to Ostomy & Urological Supplies

Member Alert: CMS Proposal May Limit Access to Ostomy & Urological Supplies

Summary: The Wound, Ostomy, and Continence Nurses Society (WOCN®) is warning clinicians, patients, and advocates about a proposed CMS rule that could threaten access to essential ostomy, urological, and tracheostomy supplies. The 2026 Home Health Prospective Payment System proposal would reclassify these supplies under the DMEPOS Competitive Bidding Program, creating serious risks for patients who depend on customized, clinically appropriate products.

Why This Matters:

  • Ostomy and urological supplies are prosthetic devices requiring individual fitting—not standardized “items.”
  • Competitive bidding prioritizes cost over patient safety, potentially limiting access to specialized products and increasing the risk of complications such as peristomal skin injury, infection, and hospitalization.
  • This change would also undermine the crucial role of WOC nurses and specialty suppliers in product selection, patient education, and ongoing support.

Action Requested: Stakeholders are urged to submit comments to CMS by August 29, 2025. Patients and caregivers can also participate using the UOAA Grassroots Portal to voice their concerns.

Key Talking Points:

  • These devices are prosthetics, not interchangeable commodities.
  • Restricting choice through bidding endangers continuity of care and may drive higher long-term costs from preventable complications.
  • Congress specifically excluded these products from competitive bidding, making the proposal an overstep of CMS’s authority.

Read the full alert on WOCN.org

Keywords:
CMS proposed rule,
ostomy supplies,
urological supplies,
DMEPOS Competitive Bidding,
WOCN,
prosthetic devices,
advocacy deadline Aug 29

WoundCon 2025: Virtual, Free, and Packed with CE Education

WoundCon 2025: Virtual, Free, and Packed with CE Education

Summary: WoundCon 2025 is the world’s largest virtual wound care conference, delivered online and on-demand. It offers evidence-based, clinician-ready strategies through three free events:

  • Spring: March 21, 2025
  • Summer: July 11, 2025
  • Fall: November 7, 2025

The events feature over 15 scientific sessions, more than 25 expert faculty, and up to 15 CE credits—all accessible for licensed healthcare professionals at no cost. (Source: HMP Global site) :contentReference[oaicite:0]{index=0}

Designed for Practice Impact:
WoundCon emphasizes “Learn Today. Apply Tomorrow.” education, tailored to a global, multidisciplinary audience including WOC nurses, podiatrists, therapists, and physicians. Each session is shaped by attendee feedback to ensure relevance and applicability. :contentReference[oaicite:1]{index=1}

New in 2025: A collaboration with the Post Acute Wound & Skin Integrity Council (PAWSIC) expands content tailored for post-acute care professionals. :contentReference[oaicite:2]{index=2}

Highlights at a Glance:

  • Free virtual access for licensed HCPs
  • Up to two weeks of on-demand playback per event
  • Accredited for Continuing Education credits (live + on-demand)
  • Program areas include wound management, policy, reimbursement, and clinical innovation

Visit the WoundCon 2025 event page

Keywords:
WoundCon 2025,
virtual wound care conference,
continuing education credits,
PAWSIC,
post-acute wound care,
HMP Global

What is the Diabetes Capital of the World?

What Is the Diabetes Capital of the World?

Summary: This Diabetes in Control post explores the oft-used label “diabetes capital of the world,” a moniker commonly applied to India due to its exceptionally high absolute number of adults living with diabetes. The piece touches on why the burden is so large—genetic susceptibility to insulin resistance, rapid urbanization, dietary shifts, and reduced physical activity—and why this matters for public health and complication prevention.

Key Points:

  • Why the label sticks: In global comparisons, India consistently ranks at or near the top for total diabetes cases. Concentrated urban growth and lifestyle changes have accelerated incidence and prevalence.
  • Risk drivers and disparities: Central obesity at relatively lower BMI, high-carbohydrate dietary patterns, and physical inactivity contribute to risk. Urban areas typically show higher prevalence than rural regions.
  • Implications for wound care: A higher diabetes burden translates into more neuropathy, PAD, and foot ulcers—raising the stakes for prevention, screening (e.g., annual foot exams), and early intervention.
  • What helps: Population-level strategies—nutrition counseling, structured physical activity, tobacco cessation, glycemic and blood pressure control—combined with primary-care screening and multidisciplinary limb-preservation programs.

Read the post on Diabetes in Control

Keywords:
India,
diabetes prevalence,
type 2 diabetes,
insulin resistance,
urbanization and health,
diabetic foot complications,
prevention and screening,
lifestyle interventions

The Courage to Do the Right Thing

The Courage to Do the Right Thing

Summary: In this reflective blog post, Dr. Caroline Fife draws on Alexis de Tocqueville’s warning that “laws are no substitute for public morality” to underscore a powerful message for healthcare: true reform only happens when individuals choose ethical behavior—even under financial pressure. With Medicare facing insolvency, she highlights how costly overbilling, driven by lax otherwise trusted professionals, fuels the crisis.

Key Insights:

  • Dr. Fife shares how, early in her career, she helped develop an EHR with built-in, point-of-care coding logic to ensure accurate, compliant billing—ultimately supporting the launch of Intellicure and later the US Wound Registry.
  • Despite the complexity of billing (e.g., over 6,000 possible E&M coding combinations), structured systems can reduce clinician burden and improve accuracy.
  • The post highlights that over 30% of Medicare billing is inappropriate—and wound care accounts for a disproportionate share—emphasizing the need for transparent quality measurement and registry-based benchmarking.
  • Dr. Fife concludes that doing the right thing—prioritizing accuracy, compliance, and honest outcomes—takes courage but is essential to sustain Medicare and deliver high-quality care.

Read the full post by Caroline Fife, M.D.

Keywords:
Caroline Fife,
accurate billing,
EHR coding,
Medicare compliance,
US Wound Registry,
ethical practice,
doing the right thing

A Breakthrough in Wound Management: LifeNet Health Unveils Dermacell® Porous

Dermacell® Porous: A Next-Generation Wound Matrix Now Widely Accessible

Summary: LifeNet Health has introduced Dermacell® Porous—an advanced human acellular dermal matrix (ADM) engineered with endogenous growth factors, collagen, and elastin—to accelerate wound closure. This new product is among the 26 skin substitute CTPs set to be covered under Medicare’s upcoming Local Coverage Determinations starting January 2026, enhancing access for clinicians and patients nationwide.

Key Benefits:

  • Designed to close chronic wounds in four or fewer applications, with a thin, durable, and naturally porous structure for optimized performance.
  • Processed using proprietary Matracell® technology, preserving native extracellular matrix components—including collagens, growth factors, matrikines, and cytokines—for enhanced vascularization and cell infiltration.
  • Sterile and shelf-stable at room temperature, ready to use straight from the package—streamlining logistics for wound care settings.
  • Early clinical feedback emphasizes faster incorporation, better integration, and more predictable healing compared to traditional scaffolds.

Clinical Impact: Medicare’s forthcoming LCD coverage—combined with Dermacell® Porous’s enhanced bioactivity and ease of use—positions clinicians to deliver more accessible and effective healing for chronic wounds, particularly in underserved settings.

Read the full article on WoundSource

Keywords:
Dermacell Porous,
LifeNet Health,
acellular dermal matrix,
CTP coverage,
chronic wound healing,
Matracell technology

A Global Consensus on Diabetic Wound Management

Global Consensus on Diabetic Wound Management: Practical, Evidence-Informed Guidance

Summary: A consensus statement published in Advances in Wound Care (2025) synthesizes expert guidance on evidence-based bedside management of diabetic wounds. It encompasses a comprehensive care framework—from addressing inflammation and glycemic control to infection containment, vascular evaluation, offloading, surgical options, pain relief strategies, dressing selection, and emerging therapies.

Expert Contributors:
Henry C. Hsia; Elof Eriksson; Geoffrey C. Gurtner; Aristidis Veves; Osama Hamdy; David J. Margolis; David G. Armstrong; Lawrence A. Lavery; Elisabeth A. Grice; Greg Schultz; Michael S. Conte; Robert S. Kirsner; Christopher E. Attinger; John S. Steinberg; Karen K. Evans; Dot Weir; Paul J. Kim; Dennis P. Orgill; Kenneth W. Liechty; J. Peter Rubin.

Take-Home Points:

  • Chronic diabetic wounds often stem from persistent, low-grade inflammation; goal-directed care must redirect the wound toward healing.
  • Optimized diabetic wound care is inherently multidisciplinary—requiring tight glycemic management, infection and biofilm control, vascular assessment (e.g., WIfI), timely revascularization, effective offloading, and when needed, surgical intervention.
  • Given rising antibiotic resistance, routine debridement and biofilm-focused topical practices are essential; systemic antibiotics should be reserved for invasive infections.
  • Limb preservation should prioritize restoring ambulation and quality of life—beyond the goal of saving tissue at any cost.

Read the full consensus statement on DiabeticFootOnline

Keywords:
diabetic wound management,
Advances in Wound Care,
WIfI system,
chronic inflammation,
biofilm management,
multidisciplinary care,
limb salvage

Exercise Caution: Before Asking and Answering Reimbursement Questions on the Internet

Exercise Caution: Before Asking and Answering Reimbursement Questions on the Internet

Summary: In this Advances in Skin & Wound Care Payment Strategies editorial, Kathleen D. Schaum, MS, warns clinicians and industry stakeholders against relying on social media and online forums for reimbursement guidance. Because coding, coverage, and payment rules vary by payer, place of service, and jurisdiction—and change frequently—generic advice can lead to denied claims, audits, and repayments.

Key Points:

  • Context matters: Reimbursement answers depend on details (payer policy, care setting, state, diagnosis, services performed). “One-size-fits-all” coding tips online are risky.
  • Common pitfall: Anonymous Q&A threads that ask “Which code should I use…?” without scenario specifics often produce incorrect, noncompliant answers.
  • Before you ask online: Include your role/setting and location, the patient’s payer(s), the diagnosis, and a succinct description of the actual services (e.g., pressure injury size/location, debridement performed, CTP application).
  • Before you answer online: Ask clarifying questions, cite official payer or coding guidance, and avoid supplying specific codes without complete context.
  • Use authoritative sources: Rely on payer bulletins, official coding manuals/guidelines, and qualified reimbursement consultants for case-specific advice.

Read the editorial in Advances in Skin & Wound Care

Keywords:
Kathleen D. Schaum,
reimbursement guidance,
wound care coding,
billing compliance,
payer policies,
online forums risks,
Advances in Skin & Wound Care

Pulsed Electromagnetic Field (PEMF) Therapy Accelerates Ulcer Healing and Bone Regeneration in Charcot Foot

Pulsed Electromagnetic Field (PEMF) Therapy Accelerates Ulcer Healing and Bone Regeneration in Charcot Foot

Summary: A randomized, single-blinded controlled trial published in Wounds (August 2025) evaluated the effect of PEMF therapy on healing outcomes in 34 patients with stage 2–3 Charcot foot ulcers. Participants were randomized to receive PEMF plus transcutaneous electrical nerve stimulation (TENS) versus TENS alone, alongside standard medical and wound care, administered three times weekly for three months.

Key Findings:

  • After 12 weeks, 94.1% of the PEMF group achieved complete radiographic resolution of Charcot foot signs, compared to only 5.9% in the control group (P < .001).
  • Median wound surface area in the PEMF group dropped to 0.0 cm² (IQR 0.0–1.0 cm²), while the control group remained at a median of 6.6 cm² (IQR 5.7–7.9 cm²), indicating significantly superior healing with PEMF (P < .05).

Why It Matters: Charcot foot involves both bone destruction and ulceration, making simultaneous bone and soft tissue healing critical. PEMF therapy appears to facilitate both—accelerating bone remodeling and promoting ulcer closure—when added to standard care.

Read the full study in Wounds

Keywords:
PEMF therapy,
Charcot foot ulcer,
bone regeneration,
wound healing,
TENS,
diabetic neuropathy

Kirschner Wires Combined With Elastic Tape for Multilayer Tension-Reducing …

Kirschner Wires + Elastic Tape for Greater Trochanter Stage 4 Pressure Injury

Summary: This intriguing case report (published in Wounds, August 2025) describes an innovative repair strategy for a large (11 × 7.5 cm), infected stage 4 pressure injury at the greater trochanter in an 89-year-old man. After multiple debridements and negative-pressure wound therapy (NPWT), clinicians employed Kirschner wires and elastic therapeutic tape to create a multilayer, tension-reducing closure.

Key Highlights:

  • The 89-year-old patient—post–hip fracture fixation and bedridden for 20 days—presented with a necrotic, foul-smelling circular ulcer. MRSA was identified, and he received appropriate antibiotics, serial debridement, and NPWT during the initial hospitalization.
  • On day 31, surgical closure was performed using five 1.5 mm Kirschner wires placed vertically and bent in an inverted “Ω” configuration to align and decompress wound edges across anatomical layers. NPWT continued post-op, followed by elastic tape as the wires were gradually removed.
  • The wound fully healed by day 102. Six-month follow-up confirmed restoration of skin appearance and sensation.
  • Authors propose that this technique effectively reduces surgical tension across skin, subcutaneous tissue, and deep fascia—without undue stress—offering a practical solution for difficult-to-close, deep trochanteric wounds.

Read the full case report in WOUNDS

Keywords:
Kirschner wires,
elastic tape,
tension-reducing repair,
Stage 4 pressure injury,
greater trochanter,
negative-pressure wound therapy (NPWT),
wound debridement

The health-related quality of life of Brazilians with epidermolysis bullosa

Moderate Quality of Life Impact in Brazilians With Epidermolysis Bullosa

Summary: A 2025 cross-sectional study published in Orphanet Journal of Rare Diseases assessed the health-related quality of life (HRQoL) among 129 individuals in Brazil living with epidermolysis bullosa (EB), revealing moderate impairment across age groups. (Read the full study)

Key Findings:

  • The sample (median age 15; ~57% female) predominantly included EB simplex cases, followed by dystrophic EB (DEB).
  • Mean Children’s Dermatology Life Quality Index (CDLQI) score: 11.01 ± 7.31—indicating moderate life quality impact. Scores on the Brazilian Portuguese Quality of Life in EB (QoLEB-BP) questionnaire mirrored this (median = 13, IQR 8–19).
  • In participants aged ≥ 17 years, higher educational level and family income correlated with better HRQoL, while being underweight was associated with poorer quality of life.
  • The DEB subtype was linked to more severe HRQoL impact compared to other EB types.

Implications: The findings underscore the significant psychosocial and functional burden of EB in Brazil, especially among those with the DEB subtype. Addressing socioeconomic disparities and nutritional challenges—and enhancing disease-specific care—are key to improving HRQoL outcomes in this population.

Keywords:
Epidermolysis bullosa,
health-related quality of life,
Children’s Dermatology Life Quality Index (CDLQI),
QoLEB-BP,
dystrophic EB,
nutritional status,
education,
Brazilian population

AVLS 39th Annual Congress

AVLS 39th Annual Congress: Venous & Lymphatic Medicine in Washington, DC

Summary: The American Vein & Lymphatic Society (AVLS) will host its 39th Annual Congress—the largest U.S. conference focusing on venous and lymphatic medicine—on October 9–11, 2025, at the Washington Hilton in Washington, DC. The event promises immersive education, hands-on workshops, and networking for clinicians and allied health professionals focused on wound, vein, and lymphatic care.:contentReference[oaicite:1]{index=1}

Highlights & Program Offerings:

  • Comprehensive curriculum: Topics span superficial, deep, and pelvic venous disease; lymphedema; lipedema; venous ulceration and wound care; emerging technologies like biosensors and bionutrients; ultrasound; dermatology for phlebologists; and practice management including reimbursement and policy frameworks.:contentReference[oaicite:2]{index=2}
  • Hands-on learning: Attendees can engage in workshops on venous ultrasound techniques, sclerotherapy, wound debridement, and compression.:contentReference[oaicite:3]{index=3}
  • Networking & social events: A welcome reception, poster sessions, Fun Run, and gala dinner await delegates.:contentReference[oaicite:4]{index=4}
  • Educational credit & inclusivity: Accredited for AMA PRA Category 1 Credits™ and recognized for nurses, sonographers, PAs, and more. Graduate trainees, allied health professionals, and students receive special registration rates.:contentReference[oaicite:5]{index=5}
  • Call for abstracts: Abstract and case submissions are open from June 20 to August 30, with award opportunities and reduced registration for accepted presenters.:contentReference[oaicite:6]{index=6}
  • Registration & rates: Early bird registration through May 31 includes discounts for members. Single-day options are available. International attendees and groups may qualify for reduced rates.:contentReference[oaicite:7]{index=7}

Visit the official AVLS Congress page

Keywords:
AVLS Annual Congress 2025,
venous and lymphatic medicine,
wound care,
ultrasound workshop,
biosensors & bionutrients,
practice management,
abstract submission,
continuing education

Are Podcasts Reasonable Forms of Education?

Practice Perfect 977 – Are Podcasts Reasonable Forms of Education?

Summary: In this reflective blog post from Practice Perfect (August 26, 2025), Jarrod Shapiro, DPM, FACFAS, FACPM, considers whether podcasts genuinely support learning—especially in medical education. He notes that passive listening, such as during a commute, yields poor retention. By contrast, incorporating active strategies—like note-taking, pausing, or discussion—substantially improves learning outcomes.

Retention Rates by Learning Method:

  • Passive Listening (podcast only): ~15–25%
  • Active Listening (with notes or summaries): ~40–50%
  • Passive Reading: ~20–30%
  • Audio-Visual Learning: ~30–50%
  • Demonstration or Observation: ~40–60%
  • Discussion or Group Learning: ~50–75%
  • Hands-On Practice: ~75–90%
  • Teaching or Immediate Application: ~90%+

Key Insight: Passive listening to podcasts does not foster true learning, as evidenced by low long-term retention. However, podcasts can be an effective educational supplement if paired with active learning techniques like discussion, application, or peer teaching.

Read the full post on Podiatry.com

Keywords:
Jarrod Shapiro,
podcasts in medical education,
learning retention,
active learning,
Practice Perfect,
medical education

Efficacy of Cellular and/or Tissue-Based Product Applications on all ….

CTP Applications Show Therapeutic Promise Across Multiple Chronic Wound Types

Summary: A retrospective real-world analysis published in Wounds (August 2025) by Carpenter et al. evaluated 446 Medicare-insured chronic wounds—including diabetic foot ulcers, venous leg ulcers, surgical, trauma, and other nonhealing wounds—treated with cellular and/or tissue-based products (CTPs) alongside standard care in non-hospital outpatient, nursing home, and home settings.

Key Findings:

  • All wound types demonstrated significant reductions in mean wound area (P < .001), with large effect sizes—e.g., surgical wounds reduced from ~10.2 cm² to ~1.96 cm² (Cohen d ≈ 1.38); trauma wounds from ~7.2 cm² to ~0.88 cm² (Cohen d ≈ 0.96).
  • Approximately 51% of wounds fully healed within up to 10 CTP applications; healing rates were highest in trauma (≈ 63%) and surgical wounds (≈ 44%), compared to DFU (≈ 41%) and VLU (≈ 32%).
  • The average number of applications among healed wounds ranged from ~4.4 (trauma) to ~6.1 (DFUs).
  • The findings align closely with prior data on DFUs and VLUs, suggesting that CTPs may serve as a broadly effective adjunct in chronic wound care across etiologies.

Read the full research in Wounds

Keywords:
cellular and/or tissue-based products (CTPs),
chronic wounds,
wound area reduction,
real-world evidence,
diabetic foot ulcer,
venous leg ulcer,
surgical wounds,
trauma wounds

Novel Zipper Device Speeds Healing of Pediatric Cutaneous Abscesses

Novel Zipper Device Speeds Healing of Pediatric Cutaneous Abscesses

Summary: A case series published in WOUNDS (Aug 2025) evaluated a noninvasive zipper-like closure device for pediatric cutaneous abscesses after incision and drainage (I&D). Across 26 cases, the device significantly reduced healing time and pain compared with traditional approaches.

Key Findings:

  • Mean healing time was 12.7 days—substantially faster than the ~21 days typical of natural healing or the ~15 days with secondary suturing.
  • Pain scores (FLACC scale) dropped from a median of 2 during device use to 0 at removal.
  • Analysis showed both infection size and the interval between I&D and zipper placement significantly predicted healing time.
  • A dose-response curve revealed a J-shaped relationship: applying the zipper between 3–5 days post-I&D optimized healing; placement beyond 8 days delayed recovery.

Clinical Implications: The zipper device offers a sutureless, low-pain, outpatient option for pediatric abscesses. Applying it optimally between 3–5 days post-I&D can shorten healing, reduce distress, and simplify care protocols.

Read the full case series on WOUNDS

Keywords:
zipper device,
pediatric abscess,
cutaneous abscess,
FLACC scale,
incision and drainage,
healing time,
outpatient closure

Rare ‘Flesh-Eating’ Bacterium Spreads North as Oceans Warm

Rare ‘Flesh-Eating’ Bacterium Spreads North as Oceans Warm

Summary: Vibrio vulnificus, a rare but deadly marine bacterium, is gradually expanding its reach northward along the U.S. coast as ocean temperatures rise. Historically concentrated in Gulf of Mexico waters, the bacterium has begun appearing more frequently in the Pacific Coast and increasingly along the Eastern shoreline. WoundCareAdvisor notes that between 150 and 200 U.S. cases are reported annually, with about 20% resulting in death, and approximately 7% of cases in 2019 occurring on the Pacific Coast.

Key Insights:

  • Cases remain rare (150–200/year), but with rising ocean temperatures and changing salinity, the geographical range of infections is expanding :contentReference[oaicite:1]{index=1}.
  • Vibrio vulnificus requires warm, brackish waters to thrive—conditions now extending further north due to climate-driven ocean warming :contentReference[oaicite:2]{index=2}.
  • Infections are highly fatal; early antibiotic treatment is critical, and clinicians in expanding risk zones should remain vigilant for necrotizing wound infections :contentReference[oaicite:3]{index=3}.

Importance: As ocean warming continues, clinicians in previously unaffected regions must become aware of Vibrio vulnificus as a potential cause of severe wound infections. Early recognition and rapid antibiotic intervention are vital to prevent tissue necrosis and systemic complications.

Keywords:
Vibrio vulnificus,
flesh-eating bacteria,
ocean warming,
necrotizing fasciitis,
climate change and infections

TNF-α-Primed Exosomes Restore Dendritic Cell Function to Accelerate T2DM Wound Healing

TNF-α-Primed Exosomes Restore Dendritic Cell Function to Accelerate T2DM Wound Healing

Summary: A study in International Journal of Nanomedicine (August 15, 2025) by Jiaqi Li et al. explores how exosomes from TNF-α-preconditioned adipose-derived MSCs (T-exos) can modulate dendritic cell (DC) dysfunction and enhance wound healing in Type 2 diabetes (T2DM).

Key Findings:

  • Under high-glucose conditions, T-exos suppressed DC activation—evidenced by decreased CD80/CD86 expression and reduced NLRP3 inflammasome activity
  • In diabetic mice, T-exos accelerated wound closure, improved collagen deposition, angiogenesis, and fibroblast proliferation
  • Mechanism: T-exos are enriched in miR-146a-5p, which targets TXNIP to inhibit NLRP3 activation; silencing miR-146a-5p negated their beneficial effects

Implications: This work positions TNF-α-primed exosomes as a novel nanotherapeutic approach that dampens inflammation while promoting tissue repair, holding promise for treating chronic wounds in T2DM.

Read the full study on Dovepress

Keywords:
TNF-α-primed exosomes,
dendritic cells,
Type 2 diabetes mellitus,
NLRP3 inflammasome,
miR-146a-5p,
TXNIP,
wound healing

Adaptive Wound Care and Sports Medicine: A Convergence of Care

Adaptive Wound Care and Sports Medicine: A Convergence of Care

Summary: In this Podiatry Today interview (August 6, 2025), Alton R. Johnson, Jr., DPM, DABPM, FACPM, FASPS, CWSP and Jeffrey Waldmuller, CP explain how principles from adaptive sports medicine translate to wound care for people with disabilities. They emphasize individualized care plans, real-time problem solving inside prosthetic/socket systems, and the importance of keeping athletes training consistently while protecting skin integrity.

Key Takeaways:

  • Define & tailor “adaptive wound care”: Think beyond standard protocols—account for prosthetic interfaces, wheelchair biomechanics, liners, sweat/maceration management, and activity goals.
  • Early detection & patient education: Athletes should adjust immediately at the first sign of friction, redness, or moisture buildup to prevent breakdown inside the prosthetic system.
  • Material matters: Liner/adhesive and dressing choices may differ from typical diabetic foot care; plan for atraumatic options that tolerate heat, perspiration, and motion.
  • Team-based support: Collaboration across prosthetists, podiatrists, rehab, and mental health professionals helps maintain training continuity and reduce setbacks.
  • Community resources: Organizations such as the Amputee Coalition, Challenged Athletes Foundation, Ottobock programs, and local adaptive sports groups can augment clinical care and patient education.

Read the full article on Podiatry Today

Keywords:
Alton R. Johnson, Jr.,
Jeffrey Waldmuller,
adaptive wound care,
sports medicine,
prosthetic socket,
skin integrity,
atraumatic dressings,
adaptive athletes

Ankle Brachial Index: Quick Reference Guide for Clinicians

Ankle–Brachial Index: Quick Reference Guide for Clinical Use

The Ankle–Brachial Index (ABI) is a simple, noninvasive test that compares the systolic blood pressure at the ankle with that at the arm. It is widely used to detect Peripheral Arterial Disease (PAD) and guide wound care decisions.

Why ABI matters:

  • PAD Risk Screening – Detects impaired blood flow in patients at risk for lower extremity wounds.
  • Compression Safety – Determines whether compression therapy can be safely applied.
  • Referral Guidance – Helps clinicians identify patients needing vascular evaluation.

How ABI is measured:

  1. Measure systolic pressure in both brachial arteries.
  2. Measure systolic pressure in dorsalis pedis and posterior tibial arteries at each ankle.
  3. Use the formula: ABI = Higher ankle pressure ÷ Higher brachial pressure (calculate separately for each leg).

ABI Interpretation:

ABI Value Interpretation Action
1.0 – 1.4 Normal No action needed
0.9 – 1.0 Acceptable Monitor
0.8 – 0.9 Mild PAD Risk factor modification
0.5 – 0.8 Moderate PAD Specialist referral; compression with caution
< 0.5 Severe PAD Urgent vascular referral
> 1.4 Calcified vessels Further vascular testing (e.g., TBI)

Limitations: ABI may be less reliable in patients with calcified or noncompressible vessels (e.g., diabetes, renal disease, elderly). In these cases, consider Toe–Brachial Index (TBI) or other vascular testing.


Read the full article in the Journal of Wound, Ostomy, and Continence Nursing

Charcot’s Legacy in Cast and Canvas: Visual Healing in Modern Diabetic Foot Care

Charcot’s Legacy in Cast and Canvas: Visual Healing in Modern Diabetic Foot Care

Summary: This letter to the editor in The International Journal of Lower Extremity Wounds reflects on how Jean-Martin Charcot’s fusion of medicine and art still shapes contemporary diabetic foot care. Charcot’s visual pedagogy—sketches, casts, and sculptures (often in collaboration with physician-artist Paul Richer)—helped clinicians “see what others overlook,” linking bedside observation with anatomical understanding. The author argues that this visual tradition endures today through photography, advanced imaging, and creative self-expression in care.

Key Points:

  • Visual communication as therapy: Creative expression (drawing, color, symbols) can provide patients with Charcot foot a language for vulnerability, offering psychological relief and reinforcing the therapeutic potential of art.
  • Patient voice and psychosocial burden: Qualitative narratives (e.g., work cited by Jody Lucas) describe immobilization, pain, isolation, and even suicidality; patients report restricted mobility, employment disruption, and strained family roles during long casting periods.
  • Holistic, empathetic care: The piece calls for integrated models that address both biomechanical needs (e.g., total contact casting) and psychosocial dimensions—validating lived experience, promoting connection, and using visuals to bridge clinician-patient understanding.
  • Modern echoes of Charcot: While tools have evolved from plaster casts to digital imaging, the clinician’s role as careful observer and interpreter remains central to patient-centered diabetic foot care.

Read the article at SAGE Journals

Keywords:
Jean-Martin Charcot,
Paul Richer,
Jody Lucas,
Charcot foot,
visual healing,
total contact cast,
patient-centered care,
art therapy in medicine

Optimizing Nutrition Interventions for Prevention and Treatment of Pressure Injuries

Optimizing Nutrition Interventions for Prevention and Treatment of Pressure Injuries

Summary: This educational blog post by WoundSource highlights the pivotal role of nutrition in pressure injury prevention and management. The key message: regular nutritional screening is linked with lower rates of pressure injuries and shorter hospital stays.

Key Highlights:

  • Early nutritional screening helps reduce the incidence of pressure injuries and shortens length of stay in hospitalized patients.
  • A collaborative, multidisciplinary care strategy is essential for improving nutritional status and supporting skin integrity.

Read the full post on WoundSource

Keywords: nutrition interventions, pressure injuries, nutritional screening, length of stay, multidisciplinary care

Why is this Wound Not Healing? Implementing Wound Balance for Early Intervention

Why Is This Wound Not Healing? Implementing Wound Balance for Early Intervention

Summary: This free WoundSource webinar (Part of the Practice Accelerator Series) features Catherine T. Milne, MSN, APRN, ANP/ACNS-BC, CWOCN-AP, WOCNF presenting the BIOMES℠ assessment tool and how it integrates into the Wound Balance framework. The session emphasizes early intervention strategies through real patient cases, contrasting scenarios where failure to assess BIOMES factors led to deterioration with those where early recognition enabled active healing.

Webinar Details:

  • Date: Thursday, August 21, 2025 at 14:00
  • Topics Covered: The BIOMES model components and its practical role in shifting treatment from passive management to active healing.
  • Series: WoundSource Practice Accelerator Series — Chronic Wounds category.

Read the full webinar details

Keywords:
BIOMES assessment,
wound balance,
early intervention,
Catherine T. Milne,
Practice Accelerator Series,
chronic wounds

Frailty Progression and Outcomes in Patients with Diabetic Foot Ulcers

Frailty Progression and Outcomes in Patients with Diabetic Foot Ulcers

Summary: A prospective study published in Surgery (August 13, 2025) by Hong et al. from USC Keck School of Medicine examined frailty development in patients with diabetic foot ulcers (DFUs) over a 12-month period. Using the Clinical Frailty Scale, researchers followed 178 individuals to track frailty progression and its impact on clinical outcomes.

Key Findings:

  • At baseline, 42% of participants were frail and remained so after one year; 25% of those initially nonfrail developed frailty.
  • Baseline frailty was significantly associated with peripheral artery disease, myocardial infarction, and non-Hispanic ethnicity.
  • Progression to frailty among nonfrail participants was linked to peripheral artery disease (OR 4.64), nonhealing ulcers (OR 2.96), revascularization (OR 9.09), and DFU-related hospitalizations (OR 1.96).

Implications: Frailty frequently persists in DFU patients but can also develop over time. Routine frailty screening and proactive interventions—such as improving circulation, preventing hospitalizations, and supporting wound healing—may help reduce adverse outcomes.

Read the full article on Diabetic Foot Online

Keywords:
frailty progression,
diabetic foot ulcers,
Clinical Frailty Scale,
peripheral artery disease,
wound hospitalizations,
rehabilitation strategies,
USC Keck School of Medicine

The Prevalence, Aetiology and Healing Trajectories of Hard‐To‐Heal Wounds in South Africa

Hard-to-Heal Wounds in South Africa: Prevalence, Causes & Healing Patterns

Summary: This retrospective study examines the characteristics of 876 wounds in 460 individuals treated at a specialised wound care clinic in Kwazulu-Natal, South Africa. The research reports on prevalence, causes, and healing outcomes for different wound types under appropriate standard care.

Key Findings:

  • Wound Types: Acute/traumatic wounds accounted for 50% of cases. Ulcers made up 38%—including 13% diabetic foot ulcers (DFUs), 12% venous leg ulcers (VLUs), and 11% pressure injuries (PIs). Atypical wounds represented 12%.
  • Hard-to-Heal (HTH) Wounds: Defined as wounds with <40% closure after 4 weeks or requiring >12 weeks of care. These comprised 22% of patients, most commonly associated with diabetes (44%) or infection (43%).
  • Referral Delay: Significant delays were noted—on average 9 weeks for DFUs, 23 weeks for PIs, and 48 weeks for VLUs—before presentation at specialized care.
  • Healing Outcomes: Acute wounds generally healed within 4–5 weeks. Healing rates for chronic wounds varied, with many achieving closure over 4–12 weeks. Among DFUs and PIs, only two-thirds healed within 24 weeks.
  • Amputations: Overall 2%, but higher in DFUs at 15%, mostly occurring before clinic referral.

Conclusion: High prevalence of chronic and HTH wounds, combined with delayed referrals, underscores the need to recognize wound management as a specialty and improve access to advanced care in South Africa.

Read the full study on PMC

Keywords:
hard-to-heal wounds,
diabetic foot ulcers,
venous leg ulcers,
pressure injuries,
South Africa,
healing trajectories,
wound prevalence

The Trial Design of the Concurrent Optical and Magnetic Stimulation Therapy Study for Refractory Diabetic Foot Ulcers

Antimicrobial Activity of Jatropha curcas Latex Against Cutaneous Wound and Burn Infections

Published July 22, 2025 in *Infection and Drug Resistance*, this study by **Ali Salman Al‑Shami, Mokhtar Alzomor** and colleagues from Sanaa University, Yemen evaluates the antimicrobial efficacy of Jatropha curcas latex against pathogens commonly found in burn and wound infections.

Study Summary:

  • Context: The authors investigated Jatropha curcas latex as a potential topical antimicrobial agent, exploring its relevance amid rising antibiotic resistance in burn and wound care.
  • Methods: Extracted latex underwent phytochemical analysis and was tested via agar well diffusion, disc diffusion, and broth dilution against clinical isolates of *S. aureus*, *E. coli*, *K. pneumoniae*, *P. aeruginosa*, and *Candida albicans*, with standard antibiotics (tetracycline, ofloxacin, fluconazole) as comparators.
  • Results: J. curcas latex achieved inhibition zones of 23–31 mm (e.g., 31.3 mm for *S. aureus*), and MICs ranged from 6.25 mg/mL (*E. coli/K. pneumoniae/C. albicans*) to 25 mg/mL (*S. aureus/P. aeruginosa*), outperforming or matching conventional drugs :contentReference[oaicite:1]{index=1}.
  • Conclusions: The study supports J. curcas latex as a promising broad-spectrum topical antimicrobial for burn and wound infections, particularly where antibiotic-resistant organisms are prevalent. Further in vivo safety and efficacy studies are recommended.

This research underscores the therapeutic potential of plant-derived antiseptics such as J. curcas latex, which may offer effective alternatives or adjuncts to conventional antimicrobials in evolving wound care scenarios.

Keywords:
Ali Salman Al‑Shami,
Mokhtar Alzomor,
Jatropha curcas,
latex topical antimicrobial,
burn wound infection,
antibiotic resistance,
MIC

Read the full study on Dove Press

Effects of a 12-week Supervised Rehabilitation Exercise Program on Patients With Peripheral Artery Disease …

12-Week Supervised Rehab Boosts Walking & Wound Healing in PAD Patients

Summary: A retrospective cohort study in *Advances in Skin & Wound Care* (Aug 2025) evaluated 42 patients with peripheral artery disease (PAD)—many with intermittent claudication or severe ischemia—who participated in a 12-week supervised exercise component of cardiovascular rehabilitation.

At baseline, patients walked an average of 301.8 m on the 6-minute walk test. By program end, this increased to 408.3 m. Among the eight patients with wounds at baseline, all but one—who died before healing—achieved wound closure. One year post-program, only one patient developed a new wound; four underwent angioplasty, and one required a major amputation.

Significance: Supervised rehab appears to safely improve walking capacity and promote wound healing in patients with moderate to severe PAD. While promising, prospective trials are needed to confirm these findings and inform clinical practice.

Read the full study in ASWC

Keywords:
supervised rehabilitation program,
peripheral artery disease,
walking distance,
wound healing,
retrospective cohort study,
6-minute walk test,
Advances in Skin & Wound Care

Concurrent Optical and Magnetic Stimulation Therapy for Chronic Wounds

Trial Design: Concurrent Optical and Magnetic Stimulation (COMS) Therapy for Chronic Wounds

Summary: This original research article explores the trial design for Concurrent Optical and Magnetic Stimulation (COMS) therapy, a novel intervention aimed at improving outcomes in patients with chronic wounds. The study highlights how the integration of both optical and magnetic stimulation may influence wound healing by targeting biological pathways at the cellular level.

The paper details the structure of the trial, including participant selection, methodology, and anticipated endpoints. COMS therapy is presented as a potentially groundbreaking approach for treating chronic wounds, addressing the unmet need for effective, non-invasive therapies that can accelerate healing and reduce complications.

Researchers emphasize that this dual-modality approach may offer advantages over traditional single-modality treatments, providing a foundation for future clinical translation if successful.

Read the full article on HMP Global Learning Network

Keywords: COMS therapy, chronic wounds, optical stimulation, magnetic stimulation, wound healing, clinical trial

Pulsar II™ Wound Debridement: The Fastest, Virtually Pain-Free Biofilm Removal Device in Wound Care

Pulsar II™: Advanced Non-Surgical Debridement

Pulsar II™ is revolutionizing debridement with the fastest, most effective non-surgical solution on the market. Clinically proven to remove 86.9% of biofilm in just 3–5 minutes, compared to 7–13% for traditional methods, Pulsar II™ accelerates healing without pain, scalpels, or physician intervention.

This no-touch, CE & FDA-cleared device is optimized for both chronic and acute wounds, including deep or tunneling wounds via its specialized tunnel tip. Its integrated waste bag contains and neutralizes biohazard material on the spot, enhancing infection control and eliminating the need for a bio-bin.

Already used in over 50 countries and trusted by leading wound care providers, Pulsar II™ offers:

  • Faster Healing – Stimulates healthy tissue and reactivates stalled wounds
  • Pain-Free Operation – 15 PSI lavage enhances patient comfort and compliance
  • Completely Portable – Battery operated and disposable for use in any setting
  • Versatile – Use on virtually any wound (optional tunnel wound tip), with almost any fluid (tap/sterile water, saline, antimicrobial)
  • Non-Physician Use (optional) – Empowers nursing staff and home health teams
  • CMS Reimbursement Friendly – Affordable reimbursement, improves coding and eligibility
  • Cost-Saving Impact – Potential to reduce Medicare wound care spend by up to 75%

Whether in clinics, hospitals, or home settings, Pulsar II™ delivers superior outcomes and lower costs—proving that the first step to healing is simple: FIRST, CLEANSE THE WOUND.

www.woundcs.com

Keywords:
Pulsar II,
debridement,
biofilm removal,
chronic wounds,
acute wounds,
tunnel wounds,
infection control,
wound management

Lunch Bytes Webinars from Wounds Australia

Wounds Australia – Lunch Bytes Webinar Series (Wound Awareness Week)

Summary: During Wound Awareness Week (September 1–7), Wounds Australia is hosting a free “Lunch Bytes” webinar series, offering practical insights for clinicians and consumers on various wound care topics. The sessions feature expert presenters discussing prevention, management, and patient support strategies for complex wound conditions.

  • Monday, 1 SeptemberWhat does Charcot foot mean to you?
    Presented by Dr. Ben Bullen (Monash University). Covers early detection, pathogenesis, management, and health literacy in Charcot foot.
  • Wednesday, 3 SeptemberFrom Acute to Healed: Collaborative Strategies to Prevent Chronic Wounds
    Presented by pharmacist Lara Gliani and RN Melissa Freeman. Focuses on community care strategies for preventing chronic wounds.
  • Thursday, 4 SeptemberLeaky Legs & Lingering Ulcers: Tackling Lymphorrhea & Venous Disease
    Presented by Hayley Ryan (WoundRescue Pty Ltd). Explores pathophysiology and practical strategies for managing lymphorrhea and venous ulcers.
  • Friday, 5 SeptemberEarly Intervention and Recurrence Prevention in Diabetic Foot Ulcers
    Presented by Professor Dr. David Armstrong. Emphasizes the importance of early action, “ulcer remission,” predictive tools, and monitoring.
  • Saturday, 6 SeptemberCaring for Ageing Skin (consumer/carer session)
    Presented by Dr. Robyn Rayner. Offers tips on skin care for older adults, including preventing skin tears and maintaining skin health.

All sessions are available for later viewing via the on-demand archive.

🔗 View the full details on Wounds Australia’s website

Keywords: Wounds Australia, Wound Awareness Week, Charcot foot, chronic wounds, lymphorrhea, venous disease, diabetic foot ulcers, ageing skin

Complex Wounds Require Complex Approaches to Management

Complex Wounds Require Complex Approaches to Management

Summary: In this educational lecture, Marie L. Williams, DPM, DABPS, DHLS, Director of Podiatric Medical Education at Aventura Hospital, reviews the latest guidance from both the IDSA and IWGDF. She explores infectious disease considerations and surgical strategies critical for treating complex wound cases, including recognizing diabetic foot infection emergencies and planning long-term care.

Learning Objectives:

  • Identify indicators of a severe diabetic foot infection.
  • Understand when a diabetic foot condition becomes a surgical emergency in podiatric practice.
  • Develop long-term wound care and maintenance strategies.

Read the full lecture on Podiatry.com

Keywords: Marie L Williams, complex wounds, IDSA guidelines, IWGDF, diabetic foot infection, podiatric surgical emergencies, long-term wound care

Wound Bed Temperature May Help Identify Chronic Wound Infection

Wound Bed Temperature May Help Identify Chronic Wound Infection

Summary: A cross-sectional study from researchers at the University of Galway evaluated whether thermal imaging—specifically wound bed temperature—can aid clinicians in assessing potential infection in chronic wounds. A total of 267 patients with ulcers, including diabetic foot, pressure, venous, and arterial etiologies, were imaged using an infrared (IR) camera in a routine clinic setting.

Key Findings:

  • The temperature at the center of wounds strongly correlated with the average wound bed temperature (R² = 0.977), suggesting that a single-point measurement may accurately reflect the whole wound.
  • A modest correlation (Pearson r = 0.32) was found between the temperature difference (wound vs. periwound skin) and clinician-assessed infection status.
  • Thermal imaging offers a non-contact, low-cost, and easy-to-use tool that could complement visual assessment—particularly when clinical signs of infection are unclear.

This study suggests that incorporating wound temperature measurement could enhance early detection of infection and support clinical decision-making, especially in challenging nonhealing wounds.

Read the full study

Keywords: wound bed temperature, thermal imaging, chronic wound infection, non-contact assessment, University of Galway

New TEWL to Predict Diabetic Foot Ulcer Recurrence

High TEWL Predicts Diabetic Foot Ulcer Recurrence

Summary: A multicenter observational study led by the NIDDK Diabetic Foot Consortium (Sen et al., 2025) reveals that high transepidermal water loss (TEWL) at the site of closed a diabetic foot ulcer (DFU) significantly increases the risk of recurrence within 16 weeks. Using a handheld evaporimeter, researchers measured TEWL at the healed DFU and compared it to a reference site on the opposite foot.

Key Findings:

  • Among 418 patients tracked up to 16 weeks post-closure, 21.5% experienced recurrence.
  • A TEWL threshold of >30 g/m²/h marked a high-risk group—35% recurrence compared to 17% in the low-TEWL group (OR 2.66; p < 0.001). Self-reported recurrence strongly aligned with clinician assessments.
  • This study suggests that visual wound healing alone may not reflect true functional barrier restoration—defined as “invisible wound” when TEWL remains high despite closure.

Implications: Measuring TEWL post-closure may serve as a valuable biomarker to differentiate between visually healed wounds and those at risk of reopening—enabling clinicians to tailor surveillance and interventions to improve long-term outcomes and prevent relapse.

Read the full Medscape commentary

Keywords: transepidermal water loss, diabetic foot ulcer recurrence, invisible wound, Chandan K. Sen, skin barrier function

Acid-Fast Bacilli Staining for Nonhealing Ulcers

Acid-Fast Bacilli Staining Reveals Mycobacterium chelonae in a Nonhealing Ulcer

Summary: A case report in WOUNDS documents a rare instance of Mycobacterium chelonae infection in a chronic foot ulcer that failed to heal despite appropriate standard care. Acid-fast bacilli (AFB) staining and cultures identified the pathogen in an immunocompetent patient, leading to successful treatment with a four-month course of linezolid and clarithromycin, alongside antimicrobial dressings—resulting in wound closure after 10 weeks.

Case Highlights:

  • The patient, a 64-year-old woman with type 2 diabetes and managed peripheral arterial disease, had an ulcer unresponsive to multiple antibacterial regimens and debridement.
  • Routine cultures were negative, but a follow-up punch biopsy with AFB staining revealed the presence of M. chelonae.
  • The tailored antibiotic combination, coupled with silver alginate dressings, achieved healing within ten weeks.

Clinical Implications: While AFB infections are uncommon in chronic ulcers, this case underscores the importance of considering alternative pathogens when wounds are nonhealing. Clinicians should consider biopsy and AFB testing after 4–6 weeks of failed conventional care.

🔗 Read the full case report on WOUNDS


Keywords: Stephanie Behme, Shiwei Zhou, Andrew Brown, Gary Rothenberg, Mycobacterium chelonae, acid-fast bacilli, AFB culture, chronic ulcer, linezolid and clarithromycin

The Impact of an Aggressive Clinic-Based Diabetic Foot Protocol: A Single-Center Case Series

The Impact of an Aggressive Clinic-Based Diabetic Foot Protocol: A Single-Center Case Series

Summary: In this July 2025 case series published in *Wounds*, Qing Jia, MD; Xiaojing Yin, MD; Wen Qin, MD; and Jiaojiao Bai, PhD report outcomes of implementing a four-step wound hygiene protocol for diabetic foot ulcers (DFUs) at a multidisciplinary clinic in Shanghai. Over 12 weeks, the team achieved an 80% complete healing rate in 20 patients, with the remainder showing significant improvement. Pain, exudate, and wound area all improved significantly (p < 0.001).

Protocol Details:

  • Cleansing: Debridement and irrigation using povidone-iodine followed by saline.
  • Debridement: Sharp removal of necrotic tissue 1–2 times weekly.
  • Wound Edge Refashioning: Optimized margins to support healing.
  • Dressing: Application of Aquacel Ag+ Extra antimicrobial dressing, capped with cotton gauze.

Outcomes: Mean wound area reduction was 95.1%, with a healing rate of 1.32 cm²/week. The average time to closure for healed wounds was 56.4 days. No serious adverse events were reported.

Conclusion: Applying a structured wound hygiene protocol in a clinic setting can produce rapid and robust healing in DFUs. To expand access, there’s a pressing need for widespread training and scalable care models.

🔗 Read the full case series on Wounds Journal


Keywords: wound hygiene protocol, diabetic foot ulcers, Qing Jia, Xiaojing Yin, Wen Qin, Jiaojiao Bai, wound cleansing, multidisciplinary clinic

Why do older people heal more slowly?

Why Do Older People Heal More Slowly?

Summary: In this reflective piece, **Matthew Steinhauser, MD, University of Pittsburgh**, explores why aging delays wound healing, using the case of an 83-year-old patient whose minor leg wound took nearly two months to close. The contrast to a child’s quick healing highlights the impact of age.

Key Factors Explained:

  • Slowed Recovery Phases: Aging disrupts all three classic healing stages—inflammation, regeneration, and remodeling—making transitions sluggish and less effective.
  • Age-Related Diseases: Conditions common in older adults, like diabetes and poor circulation, impair tissue oxygenation and hinder the regenerative stage of healing.
  • Cellular Senescence: Aging cells lose their ability to divide, thinning skin and diminishing repair. Senescent cells also produce inflammatory byproducts that further delay healing.
  • Systemic Impact: These impaired mechanisms are not limited to skin but affect healing across all tissues, with senescent inflammation often compounding injury recovery.

🔗 Read the full article on Wound Care Advisor


Keywords: Matthew Steinhauser, aging and wound healing, cellular senescence, diabetes and healing, regenerative phase of healing, chronic skin wounds

The Role of Communication in Managing Chronic Lower Limb Wounds

The Role of Communication in Managing Chronic Lower Limb Wounds

Summary: Published in the Journal of Multidisciplinary Healthcare (June 25, 2025), this narrative review by Davide Costa and Raffaele Serra explores how effective communication—between clinicians, and between providers and patients—impacts outcomes in chronic lower limb wound care. The authors examine patient education, health literacy, remote care technologies, interdisciplinary teamwork, and culturally sensitive strategies.

Key Insights:

  • Structured, empathetic provider-patient communication improves adherence, early detection, and supports emotional well-being.
  • Interdisciplinary communication frameworks like SBAR and integrated electronic records reduce errors and improve care coordination.
  • Innovations like telemedicine, mHealth apps, and AI-based chatbots expand access and reinforce patient engagement.
  • Persistent barriers include low health literacy, cultural and language differences, and unequal access to digital tools.
  • Addressing these challenges requires culturally tailored materials, motivational interviewing, digital literacy support, and equitable policy designs.

Conclusion: Communication is not just a clinical tool but a foundational component of chronic wound management—essential for patient adherence, team collaboration, and reducing disparities in care.

🔗 Read the full article


Keywords: chronic wounds, communication, interdisciplinary care, patient adherence, telemedicine, health literacy

Challenging the Parabola Paradigm in Transmetatarsal Amputation

Challenging the Parabola Paradigm in Transmetatarsal Amputation

Summary: In an oral abstract presented at the 2025 APMA National conference, Craig J. Verdin, DPM, DABPM, AACFAS and colleagues examined whether the residual metatarsal parabola structure truly affects function and outcomes following transmetatarsal amputation (TMA).

Key Insights:

  • A retrospective study of 57 unilateral TMA patients at Georgetown University grouped outcomes by residual parabola shape and residual length.
  • Major complications did not significantly vary by parabola shape. However, a longer second metatarsal remnant (“Type 4”) showed a weak but significant association with minor complications, possibly due to uneven plantar pressure distribution.
  • Neither parabola shape nor residual length correlated with functional outcomes or quality of life, based on the LEFS and SF-12 assessments.
  • The study suggests that achieving a “balanced” parabola—rather than strictly adhering to traditional length or shape norms—may suffice for optimal functional and clinical results.

Conclusion: This study challenges the long-held belief that maintaining a normal parabola or length post-TMA is essential. Its findings indicate that function-based planning may be more important than structural uniformity.

🔗 Read the full abstract on HMP Global Learning Network


Keywords: Craig J Verdin, metatarsal parabola, transmetatarsal amputation, second metatarsal remnant, limb salvage, APMA National 2025

Defining Wound Bed Conformability: Introducing the Relative Swelling Rise Test

Defining Wound Bed Conformability: Introducing the Relative Swelling Rise Test

Summary: A recent study in the Journal of Wound Care presents a novel, validated method—the Relative Swelling Rise (RSR) test—for measuring how well foam dressings conform to wound beds after absorbing fluid. Conducted by Mary R. Brennan, David H. Keast, Kimberly Bain, Mark Bain, Bo Lorentsen, and Nayla Ayoub, the methodology was independently replicated and validated to ensure reliability and clinical relevance.

Key Findings:

  • The RSR test evaluates conformability by measuring the swelling height of foam dressings relative to a fixed-diameter aperture using circular fences to prevent lateral spread.
  • Biatain Silicone foams tested using this method demonstrated average conformability ratios (α) between 0.30 and 0.60, with low variability (1–3%), indicating strong measurement reliability.
  • This test provides a reproducible and objective way to benchmark wound dressing conformability—an important factor for promoting healing and potentially reducing treatment costs.

Conclusion: The RSR test offers clinicians and product developers a powerful new tool to quantify and compare foam dressing performance—moving beyond unverified claims and toward evidence-based selection for improved wound outcomes.

🔗 Read the full article


Keywords: wound bed conformability, Relative Swelling Rise test, foam dressings, Mary R Brennan, David H Keast, Kimberly Bain

The Frank & Lizzie Show: Real World Perspectives on Kerecis Fish Skin Grafts from Iceland

Clinician Insights from the Northern Lights Scientific Wound Workshop: Kerecis in Practice

Summary: In this episode of The Frank & Lizzie Show (premiered March 27, 2025), hosts Frank and Lizzie interview over 20 clinicians at the Northern Lights Scientific Wound Workshop to discuss their experiences using Kerecis® fish skin grafts. The conversations feature nurse practitioners, physician assistants, podiatrists, and physicians who share cases involving complex dermatological wounds, diabetic foot ulcers, pressure injuries, and other challenging wounds.

Clinicians describe how Kerecis products have supported limb salvage, improved patient quality of life, and accelerated healing in difficult cases. They highlight unique product benefits, including its natural structure and bioactivity, and offer advice for colleagues considering its use. Many emphasize the transformative impact on patient outcomes and the role of Kerecis in advancing wound management strategies.

The episode captures the voices of those on the front lines, underscoring the real-world value of innovative biologic grafts in clinical practice.

🎥 Watch the full episode on YouTube


Keywords: Frank & Lizzie, Kerecis, Northern Lights Scientific Wound Workshop, fish skin grafts, diabetic foot ulcers, pressure injuries, wound healing, limb salvage

ADM Hydrogel vs. Alginate Dressings in Chronic Trauma Wounds

New Trial: ADM Hydrogel vs. Alginate Dressings in Chronic Trauma Wounds

A new randomized interventional study (NCT06978569) from the Isfahan University of Medical Sciences is evaluating whether an injectable **acellular dermal matrix (ADM) hydrogel** is more effective than standard **alginate dressings** in promoting healing of chronic traumatic wounds.

Study Design & Objectives:

  • Participants: Approximately 130 adults aged 18–65 with chronic trauma wounds (>3 weeks, 4–20 cm² in size, ≤9 mm deep) without uncontrolled infection.
  • Interventions: One group receives ADM hydrogel applied to the wound bed (post-debridement), while the control group receives standard alginate dressings. Weekly follow-ups over 12 weeks will monitor wound size and progress.
  • Primary Aim: Assess whether ADM hydrogel accelerates wound reduction and improves healing compared to alginate dressings.
  • Endpoints: Wound size reduction over 12 weeks, healing rates, complications, and likely quality-of-life outcomes.

Location: Alzahra Hospital, Isfahan, Iran

Significance: If successful, this trial could introduce a more bioactive topical therapy (ADM hydrogel) for chronic wound management—beyond traditional dressing approaches.

Keywords: ADM hydrogel, alginate dressings, chronic trauma wounds, clinical trial, Isfahan University of Medical Sciences

View study details on ClinicalTrials.gov

Revolutionising diabetic foot care: a system in urgent need of reform

Revolutionising Diabetic Foot Care: A System in Urgent Need of Reform

A compelling editorial in *The Diabetic Foot Journal* reflects on a debate with Professor Mike Edmonds regarding the future of multidisciplinary diabetic foot teams (MDFTs). Although Edmonds’ motion—that MDFTs belong solely in secondary care—won the vote, the discussion highlighted the pressing need to modernize diabetic foot care systems.

Key Insights:

  • Systemic Challenges: Rising prevalence of diabetic foot complications strains current services. Issues include gaps in access, underfunding, diminished staffing, and outdated models of care that struggle to adapt to evolving demands.
  • Learning from the Past: While early MDFTs—pioneered in the 1980s—improved outcomes, current infrastructure and resource limitations now hinder effectiveness, reminiscent of a once-dominant sports team that failed to evolve.
  • Global Innovation: Countries like Australia and the Netherlands have implemented telemedicine, integrated care models, and AI tools to improve workflows and diagnostics. These models offer a roadmap for modernization.
  • Virtual Wards as a Solution: The UK’s virtual ward model delivered hospital-level diabetic foot care at home, yielding significant cost savings and reduced bed occupancy. Similar programs abroad have shown promise in extending care access and efficiency.
  • What’s Next: There’s an urgent need for digital transformation, AI-supported diagnostics, enhanced patient engagement, community-based care access, and upskilling of podiatry professionals to reframe services around patient needs—not just the system’s convenience.

Conclusion: Modernizing diabetic foot care requires bold reform—integrating technology, virtual care, and community-based approaches to create equitable, efficient, and patient-centered services. The question now is not whether change is necessary—but whether we have the courage to act.

Keywords: Mike Edmonds, multidisciplinary foot team, diabetic foot care, systemic reform, virtual wards, telemedicine, AI diagnostics, community care

Read the full editorial on Diabetes on the Net

Adaptive Wound Care and the Convergence with Sports Medicine

Adaptive Wound Care and the Convergence with Sports Medicine

At the Symposium for Advanced Wound Care Spring, a panel discussion spotlighted the intersection of adaptive medicine and wound care, emphasizing the needs of athletes with disabilities. Alton R. Johnson, Jr., DPM and Jeffrey Waldmuller, CP later expanded on this topic in a conversation with Podiatry Today, sharing insights into the challenges and innovations within this evolving specialty.

What Is Adaptive Wound Care?
Adaptive medicine supports individuals with physical disabilities—such as amputations, spina bifida, or spinal cord injuries—to achieve their athletic goals, whether professional or recreational. Dr. Johnson noted the importance of personalized care approaches, including wheelchair customization and appropriate prosthetic or footwear selection. Waldmuller described adaptive wound care as a space requiring clinicians to think creatively to support patients with both visible and invisible disabilities.

Unique Challenges for Adaptive Athletes:
These athletes often push physical boundaries. For instance, a wheelchair marathoner endures high-impact stress on their upper body and skin integrity. Amputees may face prosthetic-related wounds that demand immediate adjustment to avoid setbacks. Both experts emphasized the need for patient education so athletes can independently manage minor issues and continue training safely.

Clinical Considerations:

  • Understanding the anatomy of wheelchairs and prosthetics is essential for tailoring wound care.
  • Sweat, friction, and pressure within prosthetic sockets are common sources of wounds, particularly at the distal end of the limb.
  • Materials used in liners and dressings must accommodate the athlete’s activity level without increasing skin risk.
  • Biomechanics, such as gait and residual limb movement, influence wound healing and injury prevention strategies.

The Mental Health and Identity Component:
Waldmuller stressed that for many adaptive athletes, being sidelined can take a serious emotional toll. The ability to stay active is tied to identity and independence. Removing a prosthetic for healing purposes can trigger distress—clinicians must recognize and support the mental health needs of these patients.

Resources and Future Directions:
Educational resources for both patients and providers are critical. Organizations such as the Amputee Coalition of America, Ottobock, Challenge Athletes Foundation, and Team Catapult provide support, training, and community. Dr. Johnson advocated for the development of clinical guidelines and expert panels to further define best practices for adaptive wound care.

Conclusion: Adaptive wound care is a growing, dynamic field that blends sports medicine, prosthetics, wound prevention, and mental health support. Collaborative, personalized care is essential to helping these athletes train consistently and reach their goals.

Keywords:
Alton R. Johnson, Jr.,
Jeffrey Waldmuller,
adaptive wound care,
prosthetics,
sports medicine,
wheelchair athletes,
mental health,
wound prevention

Read the full article on HMP Global

NPIAP 2025 August Panel Meeting

2025 NPIAP August Panel Meeting in Schaumburg, IL

The National Pressure Injury Advisory Panel (NPIAP) will host its 2025 August Panel Meeting on August 21–22 in Schaumburg, Illinois. This in-person event, held at the AMC Office, will bring together pressure injury experts and stakeholders for strategic discussions and networking opportunities.

Event Details:

  • Date: August 21–22, 2025
  • Time: Thursday 10:00 AM – 5:00 PM (Dinner at 6:30 PM); Friday 8:00 AM – 1:00 PM
  • Location: AMC Office, 1061 American Lane, Suite 310, Schaumburg, IL 60173
  • Contact: Sammen Naseer (snaseer@npiap.com)

Additional Information:

  • Registration closed on August 7, 2025
  • Meeting materials including the agenda and panel book will be distributed 5–7 days prior to the event
  • Free attendance for panel members (limit two per organization)
  • Virtual accommodations available upon request

Hotel: Hyatt Regency Schaumburg (Group rate: $155, cutoff date: July 20, 2025)
Reservations: 847-605-1234 (Group Code: G-NPIA)

Keywords:
NPIAP,
Sammen Naseer,
Panel Meeting,
Pressure Injury,
Conference 2025

View official event listing on NPIAP.com

Retrospective case series: Management of diabetic foot ulcers using Prontosan®

Management of Diabetic Foot Ulcers Using Prontosan®: A Retrospective Case Series

A case series published by *Wounds International* presents ten real-world examples from the Asia-Pacific region where Prontosan® antiseptic wound-cleansing products were used to manage diabetic foot ulcers (DFUs). These cases were recognized through B. Braun’s “UndeFEETed” Excellence Case Sharing program for their innovation, cost-efficiency, and patient-centered care approach.

Case Series Highlights:

  • Patient Population: Ten patients with DFUs, many presenting with infection or high risk of amputation, were managed using a multidisciplinary strategy that included Prontosan® as the primary cleansing agent.
  • Treatment Protocol: Each case utilized Prontosan® wound irrigation solution and/or gel as part of a routine cleansing and debridement process.
  • Clinical Outcomes: All patients demonstrated significant improvement in wound healing, with many achieving full closure. No adverse reactions to Prontosan® were reported.
  • Implications for Practice: The series supports incorporating antiseptic cleansing agents like Prontosan® into comprehensive DFU care protocols to enhance healing and reduce complications.

Conclusion: The integration of Prontosan® into routine wound care for diabetic foot ulcers yielded favorable outcomes and supports its continued use in multidisciplinary clinical settings.

Keywords: Marco Romanelli, Yan Liu, Michelle Gibb, Prontosan, diabetic foot ulcers, wound cleansing, case series, Asia-Pacific wound care

Read the full case series on Wounds International

Health-related quality of life of people receiving venous leg ulcer treatment with compression therapy

Health-Related Quality of Life in Patients Receiving Venous Leg Ulcer Treatment with Compression Therapy

A randomized clinical trial published in *Wound Practice and Research* (2025) explored how different compression treatments affect the health-related quality of life (HRQoL) of patients with venous leg ulcers (VLUs) in Brazil.

Study Details:

  • Study Design: 56 patients from 22 primary healthcare services were randomly assigned to receive either high-compression bandages (Group A) or Unna’s boots (Group B).
  • Measurement Tool: HRQoL was assessed using the multidimensional Health State Short Form questionnaire at baseline and upon wound healing or at 26 weeks.
  • Results for All Participants: Group A improved by 0.093 ± 0.09 (p < 0.001); Group B improved by 0.06 ± 0.1 (p = 0.007); no significant difference between groups (p = 0.218). :contentReference[oaicite:1]{index=1}
  • Healed Ulcers: Group A: +0.109 ± 0.084 (p < 0.001); Group B: +0.113 ± 0.115 (p < 0.01); no between-group difference (p = 0.914). :contentReference[oaicite:2]{index=2}
  • Unhealed Ulcers: Group A: +0.058 ± 0.098 (p = 0.09); Group B: +0.028 ± 0.078 (p = 0.182); no significant difference (p = 0.441). :contentReference[oaicite:3]{index=3}

Conclusion: Both high-compression bandages and Unna’s boots significantly improved HRQoL in patients with venous leg ulcers, with no notable difference between the two. :contentReference[oaicite:4]{index=4}

Keywords: Ana Cláudia Fuhrmann, Fernanda Peixoto Cordova, Fatima Al Sayah, Jeffrey A Johnson, Lisiane Manganelli Girardi Paskulin, venous leg ulcer, health-related quality of life, compression therapy, primary health care

Read the full study in Wound Practice and Research

TIMERS: the race against hard to heal wounds

TIMERS: The Race Against Hard-to-Heal Wounds — Advanced Therapies & Patient-Related Factors

In Part 4 (Sections 5 and 6) of the “TIMERS: The Race Against Hard-to-Heal Wounds” series, *Wound Care Professional* Consultant Editor **Menna Lloyd Jones** explores the advanced and adjunctive product options alongside the critical impact of patient-related factors in wound management.

Advanced & Adjunctive Product Use — When and How:

  • Adjunctive therapies such as amniotic membranes, ECM scaffolds, platelet-rich plasma, bioengineered skin substitutes, negative pressure wound therapy (NPWT), oxygen therapy, stem cell treatments, and autologous skin grafts can be deployed to enhance repair and regeneration.
  • Ancillary options like chemical debriders (e.g., Santyl®, Octenidine), larval therapy, and activated carbon dressings serve purposes such as biofilm removal, odor control, and non-traumatic debridement.
  • Choice of advanced therapies must account for wound condition, infection status, cost, patient readiness, and realistic goals, ideally in the setting of multidisciplinary care.

Managing Patient-Related (Social) Factors:

  • The “S” component in TIMERS addresses social circumstances—such as patient literacy, belief systems, psychosocial status, adherence, and support networks—that profoundly influence outcomes.
  • Effective wound care requires patient engagement, tailored education, motivational interviewing, goal setting, and active listening to align care with individual life contexts.
  • Understanding and addressing these factors creates a strong foundation for healing and significantly improves the success of advanced therapies.

Conclusion: Integrating advanced wound therapies with a robust strategy for managing social and patient-related determinants under the TIMERS framework enables truly holistic, patient-centered wound management—especially vital in complex or recalcitrant cases.

Keywords:
Menna Lloyd Jones,
TIMERS framework,
advanced therapies,
adjunctive products,
patient-related factors,
holistic wound care,
debridement

Read the full article on Wound Care Professional

Six-month Outcomes of Patients Admitted for Diabetic Foot Attack

Mid-Term Outcomes in Patients Hospitalized for Diabetic Foot Attack

A retrospective observational study published in Therapeutic Advances in Endocrinology and Metabolism assessed six-month outcomes of patients admitted to a multidisciplinary diabetic foot service for diabetic foot ulcers (DFUs), comparing those with a Diabetic Foot Attack (DFA) to those with Chronic Diabetic Foot (CDF) conditions.

Study Overview:

  • Population: 141 patients, mean age 70 ± 12 years; majority male (76.6%) with type 2 diabetes (93.6%) of mean duration 22 ± 13 years.
  • Group Definitions: DFA patients had acute ischemia, moderate/severe infections, or urgent conditions requiring hospitalization. CDF patients were admitted electively for chronic DFUs.
  • DFA Characteristics: Higher rates of moderate/severe infection (81.5% vs 50% in CDF), higher HbA1c levels (67 ± 22 vs 56 ± 14 mmol/mol), and more first-time DFU assessments (59.3% vs 13.3%).

Six-Month Outcomes (DFA vs CDF):

  • Healing: 65.4% vs 60.0% (p = 0.3)
  • Major Amputation: 4.9% vs 1.7% (p = 0.2)
  • Mortality: 8.6% vs 11.7% (p = 0.5)
  • Hospital Readmission: 27.2% vs 26.7% (p = 0.8)
  • Non-fatal MALCE: 9.9% vs 23.3% (p = 0.1)

Conclusion: Despite more severe initial presentations, patients hospitalized with DFA experienced similar six-month outcomes compared to those with CDF, suggesting that urgent multidisciplinary management may lead to favorable mid-term results.

Keywords:
diabetic foot attack,
chronic diabetic foot,
DFU,
amputation risk,
hospital readmission,
MALCE,
HbA1c,
multidisciplinary wound care

Read the full study in Therapeutic Advances in Endocrinology and Metabolism

Proteases: What Are They and Why Do They Matter?

Proteases: What Are They and Why Do They Matter?

An insightful blog post on WoundSource by **Windy Cole, DPM** highlights the critical role of **proteases** in wound biology—a dual nature where they are essential for healing but can also drive chronicity when unchecked.

Key Takeaways:

  • Definition & Function: Proteases are enzymes that cleave proteins, aiding in processes like extracellular matrix (ECM) breakdown, cell migration, and remodeling during normal wound healing. :contentReference[oaicite:1]{index=1}
  • When Too Much Becomes Too Little: In chronic, non‑healing wounds, elevated protease levels—particularly MMPs—overwhelm tissue inhibitors (TIMPs), leading to damage to growth factors, ECM components, and the wound bed. :contentReference[oaicite:2]{index=2}
  • Clinical Implications: Dressings that modulate protease activity—like collagen/oxidized regenerated cellulose (ORC) matrices—can improve healing by neutralizing excessive proteases. :contentReference[oaicite:3]{index=3}
  • Diagnostics and Point-of-Care Testing: High protease activity is emerging as a biomarker for stalled healing. Rapid protease detection tools could help clinicians make more precise therapeutic decisions. :contentReference[oaicite:4]{index=4}

Conclusion: Proteases are both healing facilitators and potential destroyers—a delicate balance that wound care clinicians need to recognize and manage. Protease-targeted interventions and diagnostics hold promise for optimizing outcomes in complex wounds.

Keywords: Windy Cole, proteases, matrix metalloproteinases (MMPs), protease‑modulating dressings, protease diagnostics, chronic wound healing

Read the full post on WoundSource

Reducing the pain of hidradenitis suppurativa wounds

Reducing the Pain of Hidradenitis Suppurativa Wounds

A recent commentary in JWC Wound Central explores the significant burden of pain experienced by individuals living with hidradenitis suppurativa (HS), emphasizing the impact of wound dressings and dressing changes on quality of life. HS is a chronic inflammatory skin condition that produces deep nodules, abscesses, and draining tracts, typically in intertriginous regions. Pain is consistently cited as the most distressing and debilitating symptom by patients.

Key Findings:

  • Pain Impact: International surveys have shown that over 80% of HS patients experience pain during dressing changes, which can be severe enough to cause depression, social isolation, and impaired intimacy.
  • Dressing Challenges: Traditional gauze dressings are often painful to remove and can damage fragile wound or periwound tissue. Patients report discomfort, embarrassment, and inconvenience due to bulky or insecure dressings.
  • Advanced Dressings: Moisture-retaining, atraumatic dressings are shown to improve healing rates, reduce pain, and lower inflammation. Superabsorbent and adhesive-free systems, such as those used in HS-specific products, demonstrate significant improvements in patient-reported pain and quality of life.
  • Clinical Guidelines: Experts recommend avoiding gauze, using adhesive-free options when possible, and prioritizing dressings that enable atraumatic removal. British and international dermatology groups stress the importance of garment-secured systems and careful handling during changes.
  • Innovation in HS Dressings: A clinical trial of a HS-specific dressing system (Hidrawear) showed reduced pain, discontinued need for analgesics before dressing changes, and better overall quality of life over a 21-day period.

Conclusion: Reducing pain in HS wound management requires clinician awareness, patient-centered dressing selection, and adoption of atraumatic dressing protocols. Moisture-balanced, secure, and easy-to-change systems offer promise for improving both physical outcomes and psychological wellbeing in this underserved population.

Keywords: hidradenitis suppurativa, wound pain, moist wound healing, atraumatic dressings, Hidrawear, quality of life, SecureLock Technology

Read the full article on JWC Wound Central

Shifting Paradigms from Habit to Evidence

Shifting Paradigms from Habit to Evidence in Wound Care Practice

A recent Clinical Insights column on WoundSource by **Windy Cole, DPM** emphasizes the need for clinicians to move beyond traditional habits and towards an evidence-driven, proactive approach in wound care.

Main Themes:

  • Habitual Patterns vs. Evidence-Based Practice: Dr. Cole challenges practitioners to evaluate legacy workflows and embrace updated protocols grounded in current research.
  • Preventive over Reactive: The shift involves prioritizing preventive management—such as early infection detection, offloading strategies, and moisture balance—before wounds progress.
  • Protease and Biomarker Awareness: Understanding wound biochemistry (e.g. protease levels, MMP activity) can inform dressing choices and intervention timing.
  • Educational Empowerment: Staying current through webinars, expert opinion, and updated practice modules like Wound Balance frameworks enhances patient outcomes.

Clinical Implications: Wound care professionals should routinely question outdated practices, engage with ongoing education, and utilize clinician tools (e.g. Wound Balance, biomarker-guided dressing selection) to deliver more precise and outcome-focused care.

Keywords: Windy Cole, evidence-based practice, preventive wound care, protease biomarkers, Wound Balance, Clinical Insights, practice habits

Read the full article on WoundSource

Mapping the Footprint of Progress: A Decade of Diabetic Foot Ulcer Research

Mapping the Footprint of Progress: A Decade of Diabetic Foot Ulcer Research

In a new bibliometric analysis featured on DiabeticFootOnline, researchers review the global expansion of diabetic foot ulcer (DFU) research over the past decade (2014–2023), uncovering trends in publication volume, country contributions, scholarly influence, and emerging scientific themes.

Study Highlights:

  • Exponential Growth: Annual DFU-related publications increased nearly threefold, from approximately 387 in 2014 to over 1,060 by 2023—reflecting growing scientific and clinical focus.
  • Global Leaders: The United States led output (accounting for over 25% of total publications), with China, England, Australia, and Italy also showing strong upward trends. Major academic contributors included the University of Texas System and the University of Amsterdam.
  • Top Scholar: Professor David G. Armstrong emerged as the most prolific and highly cited author, noted especially for his 2017 NEJM paper that reframed ulcer care by emphasizing ulcer-free days.
  • Emerging Themes: While traditional topics remain central (“diabetic foot,” “risk factors,” “prevention”), newer hotspots include “ulcer recurrence,” nanotechnology (e.g., “hydrogels,” “exosomes”), and the integration of machine learning and deep learning into wound prediction and diagnostics.

Conclusion: This comprehensive analysis illustrates a maturing, interdisciplinary global research ecosystem in DFU care—driven by technology, innovation, and an evolving focus on prevention and long-term ulcer remission.

Keywords: David G. Armstrong, diabetic foot ulcer research, bibliometric analysis, ulcer recurrence, hydrogels, exosomes, machine learning, global research trend

Read the full article on DiabeticFootOnline

Another Fatal Hyperbaric Chamber Fire

Another Fatal Hyperbaric Chamber Fire

CarolineFifeMD.com reports on a tragic fatality at a hyperbaric oxygen therapy facility in Lake Havasu City, Arizona. On July 10, 2025, a clinic-operated chamber fire claimed the life of **Walter Foxcroft, as CPR efforts were unsuccessful**. The facility had opened just a year prior. No cause has been confirmed at this time.

Incident Overview:

  • Fatal Outcome: The patient—a physical therapist and owner of the clinic—was inside the chamber when the fire occurred and was pronounced dead at the scene.
  • Facility Details: The clinic commenced operations in June 2024; safety guidelines and incident details remain under investigation.

Safety Reminder: Dr. **Caroline Fife, M.D.** urges hyperbaric clinicians to ensure facility accreditation via the Undersea and Hyperbaric Medical Society (UHMS), and strict adherence to National Fire Protection Association (NFPA) 99 safety standards—especially regarding the prohibition of unapproved electronic devices in oxygen-enriched chambers.

Keywords: Caroline Fife, hyperbaric oxygen, chamber fire, safety standards, UHMS accreditation, NFPA 99, facility risk

Read the full blog post on CarolineFifeMD.com

he Dangerous Combination of Smoking, Diabetes, and Non‑Healing Wounds

The Dangerous Combination of Smoking, Diabetes, and Non‑Healing Wounds

A recent article from Diabetes in Control highlights how smoking and diabetes together significantly worsen wound healing outcomes, particularly in patients with diabetic foot ulcers. This combination accelerates tissue damage, reduces immune response, and increases the risk of infection and amputation.

Key Insights:

  • Delayed Wound Healing: Nicotine and other harmful substances in tobacco restrict blood flow, limit oxygen delivery, and impair tissue repair—slowing the healing process in diabetic wounds.
  • Compromised Immune Function: Smoking suppresses white blood cell function and interferes with the inflammatory response, increasing vulnerability to chronic infection.
  • Worsened Vascular Health: Smoking intensifies peripheral arterial disease, a common complication in diabetes, further decreasing perfusion to the lower extremities.
  • Persistent Risk: Even after smoking cessation, some of the long-term effects on collagen production and tissue regeneration may persist, requiring early and aggressive intervention.

Clinical Takeaway: Smoking is a major modifiable risk factor in wound healing. For patients with diabetes, especially those with foot ulcers, early smoking cessation is critical to prevent complications and improve healing outcomes.

Keywords: smoking, diabetes, non‑healing wounds, diabetic foot ulcers, vascular disease, immune impairment, smoking cessation

Read the full article on Diabetes in Control

Smart wound monitor poised to improve chronic infection care

‘Smart Wound Patch’ Poised to Detect and Prevent Chronic Infection

Researchers at the University of Rhode Island have developed a prototype smart wound patch that detects early signs of infection in chronic wounds—offering a potential game-changer in preventing complications like sepsis or amputation.

The flexible, bandage-like patch uses integrated sensors to monitor biomarkers in wound fluid, including pH and temperature changes. These early shifts often indicate the onset of bacterial infection or delayed healing.

Key Features:

  • Non-invasive, continuous monitoring: The patch uses real-time biosensors to detect wound changes without disturbing the dressing.
  • Wireless data transmission: Results can be sent to a smartphone or clinician dashboard, enabling timely intervention.
  • Early warning capability: By catching inflammatory trends before visible symptoms arise, it may help clinicians avoid more invasive treatments.

The lead researcher, Kunal Mankodiya, PhD, director of the Wearable Biosensing Lab at URI, envisions applications in diabetic foot ulcers, surgical wounds, and pressure injuries—where early detection of infection is critical to preventing chronicity and escalation.

Clinical Implications: With further testing and development, smart wound technologies like this could reduce hospitalizations, improve outcomes in hard-to-heal wounds, and decrease long-term care costs. The team is working toward FDA approval and future commercial deployment.

Keywords: Kunal Mankodiya, smart wound patch, chronic wounds, infection detection, wearable biosensors, University of Rhode Island

Read the full article at Medical Xpress

Obstructive Sleep Apnea: An Independent Risk Factor for Split-Thickness Skin Graft Failure

Obstructive Sleep Apnea: An Independent Risk Factor for Split-Thickness Skin Graft Failure

A recent original research article published in Wounds highlights the significant impact of obstructive sleep apnea (OSA) on outcomes of split-thickness skin graft (STSG) procedures. The retrospective study evaluated whether a diagnosis of OSA is independently associated with increased graft failure rates in surgical wound management.

Study Overview:

  • Population Studied: 259 patients who underwent STSG procedures at a tertiary wound care center between January 2017 and December 2020.
  • Primary Finding: Graft failure occurred in 23.7% of patients with OSA versus only 12.7% in patients without OSA.
  • Independent Risk: After controlling for confounding factors such as age, diabetes, smoking status, and BMI, OSA remained an independent predictor of graft failure (adjusted odds ratio 2.33).
  • Pathophysiology: The authors speculate that hypoxia, intermittent airway obstruction, and systemic inflammation associated with untreated OSA may impair tissue oxygenation and compromise graft viability.

Clinical Implications: The study emphasizes the need for screening and potential preoperative optimization of patients with known or suspected OSA undergoing STSG procedures. Greater interdisciplinary collaboration between sleep medicine and wound care teams may be warranted to improve outcomes.

Keywords: obstructive sleep apnea, split-thickness skin graft, wound healing risk factors, graft failure, surgical wound care

Read the full article at Wounds Journal

Surgical Options for Advanced Pressure Injuries

Surgical Options for Advanced Pressure Injuries

The August 2025 issue of Advances in Skin & Wound Care features an in-depth review on surgical approaches to managing advanced pressure injuries. The article examines current indications, patient selection, and procedural strategies for debridement, tissue reconstruction, and long-term wound closure in patients with stage 3 or stage 4 pressure injuries.

Key Points Covered:

  • Indications for Surgery: Persistent non-healing wounds despite optimal conservative care, exposure of bone or tendon, and recurrent infections.
  • Surgical Techniques: Sharp debridement, negative pressure wound therapy with instillation, and flap-based reconstructions such as myocutaneous and fasciocutaneous flaps.
  • Pre-Op Considerations: Nutritional status, infection control, patient mobility, and psychosocial support all impact surgical eligibility and outcomes.
  • Outcomes and Challenges: Surgical success rates are improved with multidisciplinary care and patient adherence to post-op offloading and follow-up protocols. However, recurrence remains a risk in high-pressure zones like the sacrum and ischial areas.

Clinical Relevance: Surgical intervention is not appropriate for all patients with pressure injuries, but for carefully selected individuals, it can offer faster healing and reduced infection risk. The article advocates for collaborative care planning between surgeons, wound care nurses, physical therapists, and nutritionists.

Keywords: pressure injuries, surgical debridement, flap reconstruction, wound surgery, negative pressure wound therapy, multidisciplinary wound care

Read the full article in Advances in Skin & Wound Care